TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 37, 2014, Pages E3870-E3879

  Raphaël, Maylis ^a   Lehen'kyi, V'yacheslav ^a   Vandenberghe, Matthieu ^a,e   Beck, Benjamin ^a,f   Khalimonchyk, Sergiy ^a   Abeele, Fabien Vanden ^a   Farsetti, Leonardo ^a   Germain, Emmanuelle ^a   Bokhobza, Alexandre ^a   Mihalache, Adriana ^b   Gosset, Pierre ^b   Romanin, Christoph ^c   Clézardin, Philippe ^d   Skryma, Roman ^a   Prevarskaya, Natalia ^a  

^a Université des Sciences et Technologies de Lille   (France)

^b UNIV LILLE   (France)

^c JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^d INSERM   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; LIPOCORTIN 1; ORAI1 PROTEIN, HUMAN; PROTEIN S 100; S100A11 PROTEIN, HUMAN; TRPV6 PROTEIN, HUMAN; TUMOR PROTEIN; VANILLOID RECEPTOR;

ANIMAL; APOPTOSIS; BONE TUMOR; CARCINOGENESIS; CELL MEMBRANE; CELL SURVIVAL; DISEASE COURSE; DRUG SCREENING; ENDOPLASMIC RETICULUM; HEK293 CELL LINE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHENOTYPE; PROSTATE TUMOR; PROTEIN TRANSPORT; RADIOGRAPHY; SECONDARY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; ANNEXIN A1; APOPTOSIS; BONE NEOPLASMS; CALCIUM; CALCIUM CHANNELS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PHENOTYPE; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; S100 PROTEINS; SIGNAL TRANSDUCTION; TRPV CATION CHANNELS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907235984     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1413409111     Document Type: Article

References (56)

1. Cooperberg MR, Moul JW, Carroll PR (2005) The changing face of prostate cancer. J Clin Oncol 23(32): 8146-8151.
2. Schröder FH (2010) Prostate cancer around theworld. An overview. Urol Oncol 28(6): 663-667.
3. Fixemer T, Remberger K, Bonkhoff H (2002) Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. Prostate 53(2): 118-123.
4. Raffo AJ, et al. (1995) Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 55(19): 4438-4445.
5. Clapham DE, Runnels LW, Strübing C (2001) The TRP ion channel family. Nat Rev Neurosci 2(6): 387-396.
6. Wissenbach U, et al. (2001) Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J Biol Chem 276(22): 19461-19468.
7. Peng JB, et al. (2001) CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun 282(3): 729-734.
8. Fixemer T, Wissenbach U, Flockerzi V, Bonkhoff H (2003) Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: A novel prognostic marker for tumor progression. Oncogene 22(49): 7858-7861.
9. Prevarskaya N, Skryma R, Shuba Y (2010) Ion channels and the hallmarks of cancer. Trends Mol Med 16(3): 107-121.
10. Prevarskaya N, Skryma R, Shuba Y (2011) Calcium in tumour metastasis: New roles for known actors. Nat Rev Cancer 11(8): 609-618.
11. Legrand G, et al. (2001) Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control. J Biol Chem 276(50): 47608-47614.
12. Thebault S, et al. (2006) Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 66(4): 2038-2047.
13. Vanoverberghe K, et al. (2004) Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ 11(3): 321-330.
14. Skryma R, et al. (2000) Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: Involvement in apoptosis. J Physiol 527(Pt 1): 71-83.
15. Vanden Abeele F, Roudbaraki M, Shuba Y, Skryma R, Prevarskaya N (2003) Storeoperated Ca2+ current in prostate cancer epithelial cells. Role of endogenous Ca2+ transporter type 1. J Biol Chem 278(17): 15381-15389.
16. Vanden Abeele F, et al. (2002) Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1(2): 169-179.
17. Tauzin S, et al. (2011) The naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathway. PLoS Biol 9(6): e1001090.
18. Khadra N, et al. (2011) CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation. Proc Natl Acad Sci USA 108(47): 19072-19077.
19. Zhuang L, et al. (2002) Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest 82(12): 1755-1764.
20. Flourakis M, et al. (2010) Orai1 contributes to the establishment of an apoptosisresistant phenotype in prostate cancer cells. Cell Death Dis 1: e75.
21. Vanden Abeele F, et al. (2004) Two types of store-operated Ca2+ channels with different activation modes and molecular origin in LNCaP human prostate cancer epithelial cells. J Biol Chem 279(29): 30326-30337.
22. Yuan JP, Zeng W, Huang GN, Worley PF, Muallem S (2007) STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels. Nat Cell Biol 9(6): 636-645.
23. Kovacs G, et al. (2012) Inhibition of the human epithelial calcium channel TRPV6 by 2-aminoethoxydiphenyl borate (2-APB). Cell Calcium 52(6): 468-480.
24. Peng JB, et al. (2000) Human calcium transport protein CaT1. Biochem Biophys Res Commun 278(2): 326-332.
25. Wissenbach U, et al. (2004) TRPV6 and prostate cancer: Cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression. Biochem Biophys Res Commun 322(4): 1359-1363.
26. Lehen'kyi V, Raphaël M, Prevarskaya N (2012) The role of the TRPV6 channel in cancer. J Physiol 590(Pt 6): 1369-1376.
27. Bödding M, Flockerzi V (2004) Ca2+ dependence of the Ca2+-selective TRPV6 channel. J Biol Chem 279(35): 36546-36552.
28. Schindl R, Kahr H, Graz I, Groschner K, Romanin C (2002) Store depletion-activated CaT1 currents in rat basophilic leukemia mast cells are inhibited by 2-aminoethoxydiphenyl borate. Evidence for a regulatory component that controls activation of both CaT1 and CRAC (Ca(2+) release-activated Ca(2+) channel) channels. J Biol Chem 277(30): 26950-26958.
29. Nijenhuis T, Hoenderop JG, Bindels RJ (2005) TRPV5 and TRPV6 in Ca(2+) (re)absorption: Regulating Ca(2+) entry at the gate. Pflugers Arch 451(1): 181-192.
30. Schindl R, et al. (2012) Canonical transient receptor potential (TRPC) 1 acts as a negative regulator for vanilloid TRPV6-mediated Ca2+ influx. J Biol Chem 287(42): 35612-35620.
31. 2+ signals required for specific cell functions. PLoS Biol 9(3): e1001025.
32. van de Graaf SF, Chang Q, Mensenkamp AR, Hoenderop JG, Bindels RJ (2006) Direct interaction with Rab11a targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol 26(1): 303-312.
33. van de Graaf SF, et al. (2003) Functional expression of the epithelial Ca(2+) channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex. EMBO J 22(7): 1478-1487.
34. Lu P, Boros S, Chang Q, Bindels RJ, Hoenderop JG (2008) The beta-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant 23(11): 3397-3402.
35. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE (2004) Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol 6(8): 709-720.
36. Lehen'kyi V, Flourakis M, Skryma R, Prevarskaya N (2007) TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene 26(52): 7380-7385.
37. Lipskaia L, Lompré AM (2004) Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol Cell 96(1): 55-68.
38. Loh C, et al. (1996) Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271(18): 10884-10891.
39. Baksh S, et al. (2002) NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 10(5): 1071-1081.
40. Caetano MS, et al. (2002) NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: Evidence of its involvement in the control of cyclin gene expression. FASEB J 16(14): 1940-1942.
41. Viola JP, Carvalho LD, Fonseca BP, Teixeira LK (2005) NFAT transcription factors: From cell cycle to tumor development. Braz J Med Biol Res 38(3): 335-344.
42. Nilius B, et al. (2002) Fast and slow inactivation kinetics of the Ca2+ channels ECaC1 and ECaC2 (TRPV5 and TRPV6). Role of the intracellular loop located between transmembrane segments 2 and 3. J Biol Chem 277(34): 30852-30858.
43. Nilius B, et al. (2003) The carboxyl terminus of the epithelial Ca(2+) channel ECaC1 is involved in Ca(2+)-dependent inactivation. Pflugers Arch 445(5): 584-588.
44. Lehen'kyi V, Shapovalov G, Skryma R, Prevarskaya N (2011) Ion channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis. Am J Physiol Cell Physiol 301(6): C1281-C1289.
45. Monet M, et al. (2010) Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 70(3): 1225-1235.
46. Prevarskaya N, Skryma R, Shuba Y (2004) Ca2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochem Biophys Res Commun 322(4): 1326-1335.
47. Gonzalez VM, Fuertes MA, Alonso C, Perez JM (2001) Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 59(4): 657-663.
48. Di Sano F, et al. (2006) Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism. J Biol Chem 281(5): 2693-2700.
49. Nawrocki ST, et al. (2005) Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res 65(24): 11658-11666.
50. Baldwin AS (2012) Regulation of cell death and autophagy by IKK and NF-κB: Critical mechanisms in immune function and cancer. Immunol Rev 246(1): 327-345.
51. Yates LL, Górecki DC (2006) The nuclear factor-kappaB (NF-kappaB): From a versatile transcription factor to a ubiquitous therapeutic target. Acta Biochim Pol 53(4): 651-662.
52. Mengel B, et al. (2010) Modeling oscillatory control in NF-κB, p53 and Wnt signaling. Curr Opin Genet Dev 20(6): 656-664.
53. Verma A, Mehta K (2007) Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: A new therapeutic opportunity. Curr Cancer Drug Targets 7(6): 559-565.
54. Flourakis M, et al. (2006) Passive calcium leak via translocon is a first step for iPLA2-pathway regulated store operated channels activation. FASEB J 20(8): 1215-1217.
55. Zhao Y, et al. (2007) Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 67(12): 5821-5830.
56. Muik M, et al. (2008) Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J Biol Chem 283(12): 8014-8022.